Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Cited by (826)

Items 601–700 of 826

1. Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases
   Yuji Yamamoto, Yuya Shirai, Kyuto Sonehara, Shinichi Namba, Takafumi Ojima, Kenichi Yamamoto, Ryuya Edahiro, Suzuki Ken, Akinori Kanai, the BioBank Japan Project et al. · 2025 · Nature Communications
2. Prognostic Impact of Fibroblast Growth Factor 21 in Patients With Heart Failure
   Hiroaki Sunaga, Kuniko Yoshida, Kazuki Kagami, Tomonari Harada, Tsukasa Murakami, Naoki Yuasa, Hiroki Matsui, Keiko Kawai‐Kowase, Tatsuya Iso, Tomoyuki Yokoyama et al. · 2025 · Circulation Reports
3. Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications
   Siddharth pravin Agrawal, Lana Tannous, Ritu Chandra Prakash Tated, Darshilkumar Maheta, Jaishkar Ramesh, Hritvik Jain, William H. Frishma, Wilbert S. Aronow · 2025 · Cardiology in Review
4. FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens
   Bart J. Cooley, C. Brown, Eun Ah Choi, Willow A. Heller, A LIM, Andrew John Lawrence, Paul Haber, Gavan P. McNally, E. Zayra Millan · 2025 · Neuropsychopharmacology
5. NS5ATP6 modulates intracellular triglyceride content through FGF21 and independently of SIRT1 and SREBP1
   Zhongshu Li, Shenghu Feng, Li Zhou, Shunai Liu, Jun Cheng · 2016 · Biochemical and Biophysical Research Communications
6. Fıbroblast growth factor 21 and ıts relatıonshıp wıth ınsulın sensıtıvıty ın fırst-degree relatıves of patıents wıth type 2 dıabetes mellıtus
   Damla Ors, Alev Eroğlu Altınova, Mehmet Muhittin Yalçın, Özlem Gülbahar, Müjde Aktürk, Metin Arslan, Füsun Baloş Törüner · 2015 · Endokrynologia Polska
7. Obesity-resistance of UCP1-deficient mice associates with sustained FGF21 sensitivity in inguinal adipose tissue
   Marlou Klein Hazebroek, Susanne Keipert · 2022 · Frontiers in Endocrinology
8. Fibroblast growth factor 21 is an independent predictor of prevalent and incident obstructive sleep apnea
   Weijun Huang, Jingyu Zhang, Jianyin Zou, Xiaoting Wang, Huajun Xu, Jian Guan, Hongliang Yi, Suru Liu, Shankai Yin · 2023 · iScience
9. Associations of fibroblast growth factor 21 with cardiovascular risk and β-cell function in patients who had no history of diabetes
   Jun‐Sing Wang, Wayne Huey‐Herng Sheu, Wen‐Jane Lee, I‐Te Lee, Shih‐Yi Lin, Wen-Lieng Lee, Kae‐Woei Liang, Shing‐Jong Lin · 2017 · Clinica Chimica Acta
10. Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals
    Sharmila Rajan, Danielle Mandikian, Amos Baruch, Thomas R. Gelzleichter, Dale W. Stevens, Junichiro Sonoda, Kyra J. Cowan, C. Andrew Boswell, Eric Gary Stefanich · 2017 · mAbs
11. Association of Elevated Plasma FGF21 and Activated FGF21 Signaling in Visceral White Adipose Tissue and Improved Insulin Sensitivity in Gestational Diabetes Mellitus Subtype: A Case-Control Study
    Ning Wang, Bo Sun, Haonan Guo, Yingyu Jing, Ruan Qi, Mengjun Wang, Yang Mi, Huan Chen, Lin Song, Wei Cui · 2021 · Frontiers in Endocrinology
12. Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults
    NKIRU A. UMEKWE, Ibiye Owei, Frankie B. Stentz, Samuel E. Dagogo-Jack · 2021 · Journal of the Endocrine Society
13. An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease
    Yang Zhang, Jian-Xing Luo, Yan-Ge Li, Hongfang Fu, Fang Yang, Xiao-Yu Hu · 2022 · Evidence-based Complementary and Alternative Medicine
14. Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice
    Shantel Olivares, Anne S. Henkel · 2017 · Molecular Metabolism
15. Thymus Maintenance and Regeneration by Specific Molecular Factors
    Andrew R. Mendelsohn, James W. Larrick · 2016 · Rejuvenation Research
16. Physiological and pathological gestational cardiac hypertrophy: what can we learn from rodents?
    Maurilio Sampaolesi, Kristel Van Calsteren · 2017 · Cardiovascular Research
17. Investigation of the Characteristics of Crimean Congo Hemorrhagic Fever Cases Reported in Afyonkarahisar Province
    Derya Korkmaz, Petek Şarlak Konya, Neşe Demirtürk · 2022 · Turkish Journal of Parasitology
18. Adipocyte FGF21 Signaling Defect Aggravated Adipose Tissue Inflammation in Gestational Diabetes Mellitus
    Lun Hua, Yi Yang, Haoqi Zhang, Xuemei Jiang, Chao Jin, Bin Feng, Lianqiang Che, Shengyu Xu, Yan Lin, De Wu et al. · 2024 · Nutrients
19. Different association of GDF15 and FGF21 with glycemic status and aging in the context of obesity
    Laura Salmón‐Gómez, Victoria Catalán, Beatriz Ramírez, Maite Aguas‐Ayesa, Amaia Rodrı́guez, Sara Becerril, Jorge Baixauli, Sonsoles Gutiérrez-Medina, Carmen Mugueta, Inmaculada Colina et al. · 2025 · GeroScience
20. Activin E upregulates uncoupling protein 1 and fibroblast growth factor 21 in brown adipocytes
    Maho Sakaki, Yuji O. Kamatari, Akira Kurisaki, Masayuki Funaba, Osamu Hashimoto · 2024 · Molecular and Cellular Endocrinology
21. Age of Cafeteria Diet Onset Influences Obesity Phenotype in Mice in a Sex-Specific Manner
    N. Bazhan, Antonyna Kazantseva, A. Dubinina, N.Yu. Balybina, T. Jakovleva, E. Makarova · 2024 · International Journal of Molecular Sciences
22. Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population
    Keita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Reina Yamamoto, Hiroaki Takayama, Atsushi Tajima, Tatsuya Yamashita et al. · 2024 · Journal of Diabetes Investigation
23. Ketogenic diet and ketone salts differentially improve cardiometabolic complications in an HFpEF rat model
    Alexandre Gonçalves, Inês Nuno Alves, Cláudia Sousa-Mendes, Daniela Miranda, Glória Conceição, João Almeida‐Coelho, Diana Martins, Isabel Marcos Miranda, Alexandre Abdelaziz Rodrigues, Carolina Germana Silva et al. · 2025 · The Journal of Physiology
24. Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver Disease
    Jody R. Dushay, Michelle Lai · 2019 · Hepatology
25. Effect of Aerobic Exercise Training on Circulating Fibroblast Growth Factor-21 Response to Glucose Challenge in Overweight and Obese Men: A Pilot Study
    Masahiro Matsui, Keisei Kosaki, Kanae Myoenzono, Toru Yoshikawa, Jieyon Park, Makoto Kuro‐o, Seiji Maeda · 2022 · Experimental and Clinical Endocrinology & Diabetes
26. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction
    Liuzhang Fan, Lingyun Gu, Yuyu Yao, Genshan Ma · 2022 · Perfusion
27. Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults
    Hae Jin Lee, Jinyoung Shon, Yoon Jung Park · 2023 · Nutrients
28. Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis
    William J. Tucker, Bradley Tucker, Andrzej S. Januszewski, Alicia Josephine Jenkins, ANTHONY C. KEECH, Bryan R. Kestenbaum, Matthew Allison, Kerry‐Anne Rye, Kwok Leung Ong · 2024 · Clinica Chimica Acta
29. Effects of Saikosaponin-A on Insulin Resistance in Obesity: Computational and Animal Experimental Study
    Min-Seong Lee, Ji-won Noh, Byung-Cheol Lee · 2024 · Chemical and Pharmaceutical Bulletin
30. Association of brown adipose tissue activity with circulating sex hormones and fibroblast growth factor 21 in the follicular and luteal phases in young women
    Hirokazu Taniguchi, Yuka Hashimoto, Narumi Dowaki, Shinsuke Nirengi · 2024 · Journal of PHYSIOLOGICAL ANTHROPOLOGY
31. Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKAy mice
    Katsunori Nonogaki, Takao Kaji, T Yamazaki, Mari Murakami · 2016 · Nutrition and Diabetes
32. Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study
    Fatemeh Yaghoubi, Mina Darand, Aazam Ahmadi Vasmehjani, Zahra Darabi, Nasir Talenezhad, Farhang Mirzavandi, Mahdieh Hosseinzadeh · 2022 · BMC Nutrition
33. Comparative transcriptomic analysis reveals the underlying molecular mechanism in high-fat diet-induced islet dysfunction
    Shengrong Wan, Ying An, Wei Fan, Fang‐Yuan Teng, Zongzhe Jiang · 2023 · Bioscience Reports
34. Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity
    Yi‐Ying Kuo, Hao-Yeh Tsai, Yu‐Min Kuo, Shun‐Fen Tzeng, Po-See Chen, Po‐Hung Hsu, Ya‐Tin Lin, Pei‐Chun Chen · 2023 · Life Sciences
35. Fibroblast growth factor 21 (FGF-21) in obese children: no relationship to growth, IGF-1, and IGFBP-3
    Thomas Reinehr, Christian Ludwig Roth, Joachim Woelfle · 2016 · Hormone Molecular Biology and Clinical Investigation
36. Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
    Ghalam-Hosein Yaghoobi, Saeed Shokoohi-Rad, Hamid Jafarzadeh, Elham Abodollahi · 2020 · Journal of Ophthalmic and Vision Research
37. UPRmt-regulated mitokines: novel strategies for myocardial injury repair
    Weinan Gao, Jia Liu, William Zhang, Bin Liu, Luyan Shen · 2025 · Frontiers in Cell and Developmental Biology
38. Can Myokines Serve as Supporters of Muscle–Brain Connectivity in Obesity and Type 2 Diabetes? Potential of Exercise and Nutrition Interventions
    Heaji Lee, Yunsook Lim · 2025 · Nutrients
39. Whole-brain Mapping Reveals Diet-dependent Neuronal Activation and Selective Resistance to Exogenous FGF21
    Jieyi Meng, Xi Chen, Yi Zhu · 2025 · Endocrinology
40. Deletion of GFRAL blunts weight lowering effects of FGF21 in female mice
    Alberte Silke Buch-Rasmussen, Helle Andersen, Christina Stage, Ann Maria Kruse Hansen, Sarah Juel Paulsen, Matthew Paul Gillum, Birgitte Andersen, Anna Secher, Markus Robert Latta, Christoffer Clemmensen et al. · 2025 · Journal of Endocrinology
41. Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
    Lun Hua, Wen Shen, Dengfeng Gao, Yi Yang, Xiaohan Yang, Haoqi Zhang, Siyuan Liu, Luting Liu, Yaxue Cao, Xuemei Jiang et al. · 2025 · Cell Reports
42. Plasma Levels of Fibroblast Growth Factor 21 and Adverse Kidney Outcomes
    Hee Byung Koh, Hyo Jeong Kim, Hyung Woo Kim, Tae Ik Chang, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Seung Hyeok Han · 2025 · Mayo Clinic Proceedings
43. Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
    Hao Liu, Xiayun He, Xiaoyan Deng, Jing-Lu Yan · 2023 · BMC Musculoskeletal Disorders
44. The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
    Lili You, Xiaosi Hong, Hongshi Wu, Diefei Liang, Feng Li, Dinghao Zheng, Xiuwei Zhang, Dan Liu, Qingyu Chen, Li Yan et al. · 2023 · BMC Endocrine Disorders
45. Plasma fibroblast growth factor 21 and risk of cognitive impairment among patients with ischemic stroke.
    Xiaowei Zheng, Zheng-Bao Zhu, C. Zhong, D. Guo, Xiao-Qing Bu, Peng Hao, Tan Xu, Yong-Hong Zhang · 2024 · Neuroscience
46. Metabolic Response After a Single Maximal Exercise Session in Physically Inactive Young Adults (EASY Study): Relevancy of Adiponectin Isoforms
    Johnattan Cano-Montoya, Amanda Bentes, Yanara Pavez, Paola Andrea Rubilar, Carolina Lavoz, Pamela Ehrenfeld, Viviana Sandoval, Sergio Martínez-Huenchullán · 2025 · Biomolecules
47. Association of FGF21 with Metabolic and Cardiovascular Diseases: A Mendelian Randomization Analysis
    Qingwen He, Yuguang Li, Renqiang Yu, Mengyuan Lin · 2025 · Experimental and Clinical Endocrinology & Diabetes
48. Saponins from Panax japonicus Enhance Lipolysis via Acting on FGF21-β-Klotho/FGFR1 in Obese Mice
    Tongyao Wang, Yan Huang, Mingxin Hu, Xiaofei Huang, Dianmei Yu, Liangliang Jia, Wenru Zhi, Yifei Mu, Zhiyong Zhou, Jin’e Wang · 2025 · Journal of Agricultural and Food Chemistry
49. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins
    Hirokazu Taniguchi, Nao Akiyama, Kengo Ishihara · 2019 · Journal of Nutritional Science and Vitaminology
50. Impact du FGF21, une hormone du métabolisme énergétique, sur la reproduction
    Guillaume Bourdon, Pascal Froment, Pierre‐Henri Ducluzeau · 2021 · médecine/sciences
51. Circulating fibroblast growth factor 21 links hemodynamics with kidney function in middle-aged and older adults: A mediation analysis
    Masahiro Matsui, Keisei Kosaki, Makoto Kuro‐o, Chie Saito, Kunihiro Yamagata, Seiji Maeda · 2021 · Hypertension Research
52. Pattern of Adiponectin, Osteocalcin, Irisin, FGF-21, and MCP-1 According to the Body Size Phenotype: Could They Be Markers of Metabolic Health in Mexican-Mestizo Middle-Aged Women?
    Lourdes Balcázar‐Hernández, Lourdes Basurto, Leticia Manuel Apolinar, Sara Vega-García, Norma Eleane Basurto-Acevedo, Carlos Martínez Murillo, Rosalinda Sánchez‐Arenas · 2021 · Metabolites
53. Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
    Qin-Ying She, Lijuan Li, Ming-Hong Liu, Ru-Yu Tan, Yi-Wen Zhong, Jing‐Fu Bao, Jie-Dong Xie · 2022 · Frontiers in Pharmacology
54. HYPOTHesizing about central comBAT against obesity
    Ismael González‐García, Edward Milbank, Anxo Martínez-Ordóñez, Carlos Diéguez, Miguel López, Cristina Contreras · 2019 · Journal of Physiology and Biochemistry
55. Obésité, inflammation et COVID-19 : intérêt préventif de l’alimentation cétogène ?
    Anouk Charlot, Rimel Boumiza, Margot Roux, Joffrey Zoll · 2021 · Biologie Aujourd hui
56. Efficacy of fibroblast growth factor 21 in non‐alcoholic fatty liver disease in guinea pigs
    Julie Hviid Klæbel, Jens Lykkesfeldt, Pernille Tveden‐Nyborg · 2022 · Basic & Clinical Pharmacology & Toxicology
57. Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess
    Marta Díaz, José Miguel Gallego-Escuredo, Francis de Zegher, Francesc Villarroya, Lourdes Ibáñez · 2015 · Diabetes & Metabolism
58. Therapeutic potential of FGF21 in diabetes
    Della Davis, Chetna Garg, SS Lahiri · 2017 · Journal of Medicinal Plants Studies
59. Association of circulating FGF-21 levels in the first week of life and postnatal growth in hospitalized preterm infants
    Kyoung Eun Joung, Dana M. Clausen, Aimee R. Herdt, Amy Presti, Ruth Snyder, Caryn Peters, Helen A. Christou, Christos Socrates Mantzoros · 2020 · Metabolism Open
60. The authors reply: Letter on: “Fibroblast growth factor 21 controls mitophagy and muscle mass” by Oost et al.
    Lynette J. Oost, Marco Sandri, Vanina Romanello · 2019 · Journal of Cachexia Sarcopenia and Muscle
61. The Anti-Obesity Effect of Fish Oil in Diet-Induced Obese Mice Occurs via Both Decreased Food Intake and the Induction of Heat Production Genes in Brown but Not White Adipose Tissue
    Takahiko Obo, Hiroshi Hashiguchi, Eriko Matsuda, Shigeru Kawade, Kazuma Ogiso, Haruki Iwai, Koji Ataka, Osamu Yasuda, Aiko Arimura, Takahisa Deguchi et al. · 2024 · International Journal of Molecular Sciences
62. Fenofibrate treatment during lactation prevents liver and adipose tissue associated metabolic dysfunction in a rat model of childhood obesity
    Lucas Paulo Jacinto Saavedra, Scarlett Rodrigues Raposo, Ana Letícia Manso Assakawa, Naiara Cristina Lucredi, Maria Natália Chimirri Peres, Silvano Piovan, Géssica Dutra Gonçalves, Veridiana Mota Moreira, Letícia Ferreira Barbosa, Diana Sousa et al. · 2025 · Biomedicine & Pharmacotherapy
63. The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH
    Jenny Norlin, Maria Dermit, Nikos Sidiropoulos, Elisabeth Douglas Galsgaard, Henrik H. Hansen, Michael Feigh, Sanne Skovgård Veidal, Markus Robert Latta, Emma Henriksson, Birgitte Andersen · 2025 · PLoS ONE
64. The role of fibroblast growth factor 21 in diabetes and metabolic dysfunction
    Ashirvad Jaiswal, Chadani Nigam, Gaurish Narayan Singh, Anurag Kumar Gautam · 2026 · Molecular Biology Reports
65. The role of β-Klotho in FGF signaling: from molecular insights to therapeutic innovations
    Fang Yan, Chen Yang, Shiyuan Huang, Li Yuan, Yi Qiu, Tao Liu, Xi Peng, Yang Yang · 2026 · American Journal of Physiology-Endocrinology and Metabolism
66. FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
    Ewa Szczepańska, Piotr Glinicki, Wojciech Zgliczyński, Jadwiga Slowinska-Srzednicka, Helena Jastrzębska, Małgorzata Gietka‐Czernel · 2022 · Frontiers in Endocrinology
67. Acute effects of moderate-intensity constant training on circulatory fibroblast growth factor 21, resis-tin, and adiponectin of physically inactive young adults
    Jeremías Carrasco-Molina, Giannina Iuspa-Santelices, Francisca Flores-Ojeda, Matías Ruíz-Uribe, Sergio Martínez-Huenchullán · 2024 · Retos
68. FGF21 upregulation by hepatitis C virus via the eIF2α-ATF4 pathway: implications for interferon signaling suppression and TRIM31-mediated TSC degradation
    Liang Liu, Masahiko Ito, Satoshi Sakai, Jie Liu, Kazuyoshi Ohta, Kenji Saito, Kenji Nakashima, Shinya Satoh, Alu Konno, Tetsuro Suzuki · 2024 · Frontiers in Microbiology
69. Changes in metabolic hormones and trace elements in CSF in active smokers indicate oxidative damage to brain cells
    Peiwen Zheng, Fan Wang, Hui Li, Hanlu Chen, Meng-Tong Li, Haozheng Ma, Jue He, Li Chen, Yanlong Liu, Haiyun Xu · 2024 · Endocrine Connections
70. A Tryptophan Hydroxylase Inhibitor Increases Hepatic FGF21 Production and Decreases Hepatic Gluconeogenesis Independently of Insulin in db/db Mice
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
71. Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKAy mice
    Katsunori Nonogaki, Takao Kaji · 2020 · Heliyon
72. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
    Judita Klímová, Tomáš Zelinka, Ján Rosa, Branislav Štrauch, D Haluzíková, Martin Haluzı́k, Robert Holaj, Zuzana Krátká, Jan Kvasnička, Viktorie Ďurovcová et al. · 2019 · Cancers
73. Identification of State Markers in Anorexia Nervosa: Replication and Extension of Inflammation Associated Biomarkers Using Multiplex Profiling in Anorexia Nervosa and Atypical Anorexia Nervosa
    Lauren E. Breithaupt, Laura M. Holsen, Chunni Ji, Jie Hu, Felicia Petterway, Megan E. Rosa‐Caldwell, Ida A. K. Nilsson, Jennifer J. Thomas, Kyle A. Williams, Regine Boutin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
74. Madecassoside modulates lipid metabolism in visceral adipocytes: exploring the browning, lipolysis, and lipogenesis mechanisms for potential obesity treatment
    Wonjun Cho, Min Eui Hong, Enas H Mobarak, Oğuzhan Birdal, Min Chan Lim, Min Seok Jung, Soon Auck Hong, Ji Hoon Jeong, Tae Woo Jung · 2024 · Journal of Pharmacy and Pharmacology
75. Promotion of obesity by fibroblast growth factor 21-oxytocin system dysfunction due to sugar-specific hyperphagia
    Hajime Mori, Kanako Inoue, Sho Matsui, Yasuo Oguri, Satoshi Tsuzuki, Tsutomu Sasaki · 2025 · American Journal of Physiology-Endocrinology and Metabolism
76. B1344 ameliorates non-alcoholic steatohepatitis in HFCD-HF/G-induced mice: exploring the therapeutic efficacy and mechanism of a novel FGF21 analogue
    Zhiwei Chen, Tao Liu, Ping Huang, Yang Liu, Siyu Xu, Junyao Ding, Haiyan Song, Lili Yang, Peiyong Zheng · 2025 · European Journal of Pharmacology
77. EndoCompass project: research roadmap for diabetes, obesity, and metabolism
    Chantal Mathieu, Manuela Meireles, Uberto Pagotto, Martin Wabitsch, Indraneel Banerjee, Alberto Bartolomé, Tadej Battelino, Julia Beck, Francesco Chiarelli, Diva D. De León et al. · 2025 · European Journal of Endocrinology
78. Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD
    Karina Mireya Palacios Girón, Z. Nazará, Montserrat Maldonado‐González, Erika Martínez‐López, Martha Patricia Sánchez-Muñoz, Carlos Alfredo Bautista-López, Ma. Soledad Aldana-Aguiñaga, José Alfredo Domínguez-Rosales, Belinda Vargas‐Guerrero, Bertha Ruiz‐Madrigal · 2025 · International Journal of Molecular Sciences
79. Hepatic FGF21 Deletion Improves Glucose Metabolism, Alters Lipogenic and Chrna4 Gene Expression, and Enhances Telomere Maintenance in Aged Female Mice
    Daniel Torres‐Oteros, Mariano Nicola‐Llorente, Hèctor Sanz‐Lamora, Albert Pérez‐Martí, Pedro F. Marrero, Sı́lvia Canudas, Diego Haro, Joana Relat · 2025 · International Journal of Molecular Sciences
80. Gene regulatory mechanisms underlying sex- and age-dependent pathophysiology of MASLD
    Núria Morral · 2026 · Clinical Science
81. The role of increased FGF21 in VLDL-TAG secretion and thermogenic gene expression in mice under protein malnutrition
    Yori Ozaki‐Masuzawa, Hiroki Kosaka, Rino Abiru, Yumiko Toda, Kota Kawabata, Mari Nagata, Shohei Hara, Morichika Konishi, Nobuyuki Itoh, Takashi Hosono et al. · 2021 · Bioscience Biotechnology and Biochemistry
82. Differential effects of acute versus chronic dietary fructose consumption on metabolic responses in FVB/N mice
    Jordan W. Strober, Sully Fernandez, Honggang Ye, Matthew Brady · 2022 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
83. Association of hepatokines with markers of endothelial dysfunction and vascular reactivity in obese adolescents
    David Stein, Daniela Ovadia, Stuart D. Katz, Preneet Cheema Brar · 2024 · Journal of Pediatric Endocrinology and Metabolism
84. Analysis of serum levels and DNA methylation of fibroblast growth factor 21 using peripheral blood-derived genomes in patients with obesity
    Hiroyuki Shinozaki, Shiori Kawai, Mami Gamo-Kawasaki, Ayano Takei, Kyoko Tsujikado, Kazunori Fukuda, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Kohzo Takebayashi et al. · 2024 · Endocrine Journal
85. Evaluating Fibroblast Growth Factor 21 (FGF21) Levels Post-Gastric Sleeve Surgery in Obese Patients
    Khalid Al-Regaiey, Muhammad Iqbal, Mohammed Alzaid, Osama A Alkaoud, Mohammed A Alhadyani, Osama A. Alagel, Salem S Alshehri, Ibraheem Altamimi, Saud M Alsofayan · 2024 · Cureus
86. Hyperactive browning and hypermetabolism: potentially dangerous element in critical illness
    Lu Huang, Lili Zhu, Zhenxiong Zhao, Shenglu Jiang · 2024 · Frontiers in Endocrinology
87. Novel FGF21 analogues through structure-based optimization for therapeutic development
    Yiqing Guo, Yuxuan Bao, Zhichao Chen, Zhiheng Rao, Yongde Luo, Sheng Ye, Si Liu · 2024 · Acta Biochimica et Biophysica Sinica
88. Circulating fibroblast growth factor 21 levels in gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis
    Zhen Cao, Zhiming Deng, Juan Lü, Ying Yuan · 2025 · BMC Pregnancy and Childbirth
89. Multiomics unravels the complexity of male obesity: a prospective observational study
    Georgios E. Papadakis, Lucie Favre, Yassine Zouaghi, Nathalie Vionnet, Nicolas J. Niederländer, Michela Adamo, James S. Acierno, Dassine Berdous, Alexia Boizot, Jenny Meylan et al. · 2025 · Journal of Translational Medicine
90. The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice
    Angelo Di Vincenzo, Marnie Granzotto, Marika Crescenzi, Paola Fioretto, Roberto Vettor, Marco Rossato · 2025 · BMC Endocrine Disorders
91. Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
    Liang-Te Chiu, Chi-Di Hung, Lin Lin, Yu‐Li Lin, Bang‐Gee Hsu · 2022 · International Journal of Hypertension
92. Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood
    Yuan Xu, Kazutaka Tsujimoto, Hashimoto K, Kawahori K, Nozomi Hanzawa, Masahide Hamaguchi, Taiichiro Seki, Nawa M, Tatsuya Ehara, Yoshihisa Kitamura · 2018 · Yearbook of pediatric endocrinology
93. Anti-adiposity impact of phosphodiesterase-5 inhibitor, Sildenafil is possibly through browning of white adipose tissue and FGF21 in obese rats
    Marwa Muhammad, Sania Elwai, Shaymaa Abd El Rahman · 2019 · Bulletin of Egyptian Society for Physiological Sciences
94. Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial
    Johannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, Roland Feldbauer, Klemens Rosenberger, Michael Resl, Thomas Wagner, Florian Obendorf, Margot Egger-Salmhofer, Benjamin Dieplinger et al. · 2022 · Journal of Cellular and Molecular Medicine
95. Aortic Injury Induced by Benzo(a)pyrene and Atherogenic Diet Increased Hepatic FGF21 Expression in C57BL/6J Mice
    Farzane Shanehbandpour-Tabari, Fatemeh Gholamnataj, Nahid Neamati, Ebrahim Zabihi, Farideh Feizi, Hadi Parsian · 2024 · Iranian journal of pharmaceutical research
96. Recent advances in the adaptations of adipose tissue to physical activity: Morphology and adipose tissue cellularity
    Tetsuya Izawa, Junetsu Ogasawara, Takuya Sakurai, Sachiko Nomura, Takako Kizaki, Hideki Ohno · 2012 · The Journal of Physical Fitness and Sports Medicine
97. Relación del factor de crecimiento de fibroblastos 21 con indicadores de masa y función muscular en personas mayores con sobrepeso u obesidad. Estudio exploratorio
    Javiera Balboa-Vásquez, Ayelen Domínguez-Reyes, Yosselyn Escandón-San Martín, Francisca Pavicic, Pamela Ehrenfeld, Sergio Martínez-Huenchullán · 2021 · Revista Española de Geriatría y Gerontología
98. Endogenous GDF15 and FGF21 additively alleviate hepatic steatosis and insulin resistance in obese mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
99. Endocrinology and metabolism
    Xiaokun Li · 2024 · Elsevier eBooks
100. Fibroblast growth factor 21 is associated with widening QRS complex and prolonged corrected QT interval in patients with stable angina
     Wei‐Chin Hung, Teng‐Hung Yu, Chao-Ping Wang, Chia‐Chang Hsu, Yung‐Chuan Lu, Ching‐Ting Wei, Fu‐Mei Chung, Yau‐Jiunn Lee, Cheng‐Ching Wu, Wei-Hua Tang · 2022 · BMC Cardiovascular Disorders